Blar i Øvrige samlinger på tidsskrift "Osteoporosis International"

Viser treff 1-7 av 7

    • Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway 

      Hoff, Mari; Skurtveit, Svetlana; Meyer, Haakon E; Langhammer, Arnulf; Søgaard, Anne-Johanne; Syversen, Unni; Skovlund, Eva; Abrahamsen, Bo; Forsmo, Siri; Schei, Berit (Journal article; Peer reviewed, 2018)
      Summary Use of anti-osteoporotic drugs (AODs) was examined in a Norwegian population 50–85 years. Among them with Fracture Risk Assessment Tool (FRAX) score for major osteoporotic fracture ≥ 20, 25% of the women and 17% ...

    • Determinants of trabecular bone score and prevalent vertebral fractures in women with fragility fractures: a cross-sectional sub-study of NoFRACT 

      Borgen, Tove Tveitan; Bjørnerem, Åshild; Solberg, Lene Bergendal; Andreasen, Camilla; Figved, Wender; Hübschle, Lars Michael; Stenbro, May-Britt; Basso, Trude; Dahl, cecilie; Stutzer, Jens-Meinhard; Frihagen, Frede; Eriksen, Erik Fink; Nordsletten, Lars; Hansen, Ann Kristin; Apalset, Ellen Margrete; Gjertsen, Jan Erik; Lund, Ida (Peer reviewed; Journal article, 2019)
      Summary - Determinants of trabecular bone score (TBS) and vertebral fractures assessed semiquantitatively (SQ1–SQ3) were studied in 496 women with fragility fractures. TBS was associated with age, parental hip fracture, ...

    • Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway 

      Hoff, Mari; Skovlund, Eva; Meyer, Haakon E; Langhammer, Arnulf; Søgaard, Anne-Johanne; Syversen, Unni; Holvik, Kristin; Abrahamsen, Bo; Schei, Berit (Peer reviewed; Journal article, 2021)
      Summary Bisphosphonates reduce fractures in randomized controlled trials (RCT); however, there is less information from real life. In our population including 14,990 women and 13,239 men, use of bisphosphonates reduced ...

    • Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions 

      Canoy, D.; Harvey, Nicholas C.; Prieto-Alhambra, Daniel; Cooper, Cyrus; Meyer, H.E.; Åsvold, B.O.; Nazarzadeh, M.; Rahimi, Kazem (Peer reviewed; Journal article, 2021)
      Blood pressure and bone metabolism appear to share commonalities in their physiologic regulation. Specific antihypertensive drug classes may also influence bone mineral density. However, current evidence from existing ...

    • Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment 

      Mosti, Mats Peder; Flemmen, Grete; Hoff, Jan; Stunes, Astrid Kamilla; Syversen, Unni; Wang, Eivind (Journal article; Peer reviewed, 2016)
      Summary This study examined musculoskeletal health in amphetamine users, compared with healthy age-matched controls. We show that amphetamine users have reduced bone mass at several skeletal sites and attenuated maximal ...

    • Proton pump inhibitors and fracture risk. The HUNT study, Norway. 

      Hoff, Mari; Skovlund, Eva; Skurtveit, Svetlana; Meyer, Haakon E; Langhammer, Arnulf; Søgaard, Anne-Johanne; Syversen, Unni; Forsmo, Siri; Abrahamsen, Bo; Schei, Berit (Journal article; Peer reviewed, 2019)
      Summary Proton pump inhibitors (PPIs) have been linked to increased risk of fracture; the data have, however, been diverging. We did not find any increased risk of fractures among users of PPIs in a Norwegian population ...

    • Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway 

      Hoff, Mari; Meyer, Haakon E; Skurtveit, Svetlana; Langhammer, Arnulf; Søgaard, Anne-Johanne; Syversen, Unni; Dhainaut, Alvilde; Skovlund, Eva; Abrahamsen, B; Schei, Berit (Journal article; Peer reviewed, 2017)
      Summary Fracture Risk Assessment Tool (FRAX) without bone mineral density (BMD) for hip fracture prediction was validated in a Norwegian population 50–90 years. Fracture risk increased with higher FRAX score, and the ...